Feedback
We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
Department of Dermatology, University of Wisconsin, Madison, Wisconsin
Department of Dermatology, Perelman School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
University of Iowa Carver College of Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa
Department of Dermatology, University of Iowa Hospitals and Clinics, Iowa City, Iowa
Department of Pathology and Clinical Microbiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa
Department of Dermatology, Pathology, and Infectious Diseases, University of Iowa, Iowa City, Iowa
Angioinvasive fungal infections cause significant morbidity and mortality because of their propensity to invade blood vessel walls, resulting in catastrophic tissue ischemia, infarct, and necrosis. While occasionally seen in immunocompetent hosts, opportunistic fungi are emerging in immunosuppressed hosts, including patients with hematologic malignancy, AIDS, organ transplant, and poorly controlled diabetes mellitus. The widespread use of antifungal prophylaxis has led to an “arms race” of emerging fungal resistance patterns. As the at-risk population expands and new antifungal resistance patterns develop, it is critical for dermatologists to understand and recognize angioinvasive fungal pathogens, because they are often the first to encounter the cutaneous manifestations of these diseases. Rapid clinical recognition, histopathologic, and culture confirmation can help render a timely, accurate diagnosis to ensure immediate medical and surgical intervention. Superficial dermatophyte infections and deep fungal infections, such as blastomycosis and histoplasmosis, have been well characterized within the dermatologic literature, and therefore this article will focus on the severe infections acquired by angioinvasive fungal species, including an update on new and emerging pathogens. In the first article in this continuing medical education series, we review the epidemiology and cutaneous manifestations. The second article in the series focuses on diagnosis, treatment, and complications of these infections.
Credit Types: | CME / MOC |
Credit Amount: | 1.00 Credits |
Release Date: | 2019-Apr-01 |
Expiration Date: | 2022-Apr-01 |
Estimated Time for Completion: | 1 hour |
Registration Required: | Yes |
Cost: | $0.00-$39.95 |
System Requirements: CME is free with premium AAD membership. CME can be purchased individually for $35.95. |
"OpenCME has initially been made available in a "beta" edition with minimal content, functionality and online presence. Our editorial team is working hard to add many other specialty areas to the list above."
Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.
Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.